NWGCP 2025: PharmaGenDRx Unites India for Good Clinical Practice with 200+ Participants

Date:

Share post:

NWGCP 2025: PharmaGenDRx Unites India for Good Clinical Practice with 200+ Participants

PharmaGenDRx News Bureau – 4th August,2025

01:00 PM IST


PharmaGenDRx and ABS Clinical Solutions jointly in collaboration with Bioequivalence
Study Centre, Jadavpur University, hosted a National Workshop on Good Clinical Practice
(NWGCP) on 2nd August,2025. The workshop delivered the importance of ethical compliance and how to
elevate scientific standards governing clinical research and trials in India.


The workshop drew a remarkable participation of over 200 participants, including
researchers, academicians, clinicians and industry professionals joining both in-person and
via online platforms. The event served as a vital platform for knowledge exchange, policy
insights and fostering future ready clinical research practices with special keynote sessions
and poster presentations. To amplify the message this event was promoted by digital media
partners- PharmaTutor, Being Pharmacist and Pharmacist Tanyeem towards a broader Pharma
community.


The keynote session featured distinguished speakers from renowned healthcare institutions of
Kolkata, Prof Dr Suparna Chatterjee (Department of pharmacology, IPGMER), Prof.Dr Avijit
Hazra (Dean of student affairs, IPGMER, SSKM) and Dr. Supriyo Chowdhury (Assistant
Director research, institute of Neurosciences).


They delivered in-depth perspectives, highlighting current trends of clinical trials, regulatory
frameworks, ethics in human research and the integration of Good Clinical Practice (GCP)
principles across academia and industry.


The NWGCP workshop is a testament to PharmaGenDRx’ s commitment to fostering a
culture of quality, transparency and accountability in clinical research. It holds an important
position in PharmaGenDRx’ s annual flagship initiative since 2024 which not only supports
the academic community but also contributes significantly to the nation’ s broader goals in
global health research and innovation.


Stay updated with upcoming Workshops, Conferences and events organized by
PharmaGenDRx, visit our official website www.pharmagendrx.com

By Arundhuti Chatterjee and Sharon Bose

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...